FDA Recalls Jardiance Diabetes Tablets Due to Storage Temperature Deviations
Jardiance 25 mg tablets distributed nationwide were recalled due to CGMP deviations where products were exposed to temperatures outside the labeled storage conditions. The recall affects batch D41919.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary precautionary recall related to a manufacturing practice deviation. FDA Class II recalls without confirmed product failure or reported patient harm are classified as Moderate per the recall severity rubric.
Plain-English summary
Jardiance (empagliflozin) 25 mg tablets, 30-tablet packs, have been recalled nationwide due to Current Good Manufacturing Practice (CGMP) deviations. According to the recall, products were exposed to temperatures outside the labeled storage conditions, which affects pharmaceutical stability and product quality.
The recall applies to batch D41919 (NDC 0597-0153-37), distributed throughout the United States. Jardiance is manufactured and distributed by Boehringer Ingelheim Pharmaceuticals, Inc., and is indicated as a prescription medication for diabetes management.
Patients taking this medication should contact their pharmacy or healthcare provider regarding the recall and potential next steps.
The recalled product
- Product
- JARDIANCE (EMPAGLIFLOZIN)
- Brand
- JARDIANCE
- Manufacturer
- CARDINAL HEALTHCARE
- Category
- Drug
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch D41919
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 42 recalled by CARDINAL HEALTHCARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 42 products in this recall →Related recalls
Same brand · JARDIANCE
- HighPrescription Drug Recall: Jardiance Empagliflozin 25 mg Label Mix-Up
FDA (Drugs) · 2023-03-29
Same manufacturer · CARDINAL HEALTHCARE
See all →- HighAlbuterol Sulfate Inhaler Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateMeloxicam 15 mg tablets recalled for exposure to improper storage temperatures
FDA (Drugs) · 2024-01-03
- HighPredniSONE Tablets Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighLow-dose aspirin recall due to improper storage temperature conditions
FDA (Drugs) · 2024-01-03
- HighBumetanide Tablets Recalled for Exposure to Improper Storage Temperatures
FDA (Drugs) · 2024-01-03
Same hazard · improper storage
See all →- ModerateFairhope Cold Brew Coffee Concentrate Recall Over Missing Refrigeration Label
FDA (Food) · 2026-06-24
- ModerateOrtho Clinical Diagnostics Total Bili-Alkp XT Reagent Recall
FDA (Devices) · 2025-06-04
- ModerateHemoCue HemoTrol High Control Product Recalled Due to Storage Conditions
FDA (Devices) · 2025-06-04
- ModerateAbbott Rapid DX Multi Analyte Control Affected by Storage Temperature Excursion
FDA (Devices) · 2025-06-04
- ModerateAbbott Diagnostics HIV Combo Calibrator Affected by Cold Chain Exposure
FDA (Devices) · 2025-06-04